These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34119028)

  • 1. Advances in familial hypercholesterolaemia in children.
    Reijman MD; Kusters DM; Wiegman A
    Lancet Child Adolesc Health; 2021 Sep; 5(9):652-661. PubMed ID: 34119028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of homozygous familial hypercholesterolaemia in paediatric patients: A monocentric experience.
    Buonuomo PS; Macchiaiolo M; Leone G; Valente P; Mastrogiorgio G; Gnazzo M; Rana I; Gonfiantini MV; Gagliardi MG; Romano F; Bartuli A
    Eur J Prev Cardiol; 2018 Jul; 25(10):1098-1105. PubMed ID: 29785886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous familial hypercholesterolaemia: update on management.
    France M
    Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous familial hypercholesterolaemia in childhood: cardiovascular risk prevention.
    van der Graaf A; Kastelein JJP; Wiegman A
    J Inherit Metab Dis; 2009 Dec; 32(6):699. PubMed ID: 19898954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe familial hypercholesterolaemia: current and future management.
    Farnier M; Bruckert E
    Arch Cardiovasc Dis; 2012 Dec; 105(12):656-65. PubMed ID: 23199621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France.
    Bruckert E; Kalmykova O; Bittar R; Carreau V; Béliard S; Saheb S; Rosenbaum D; Bonnefont-Rousselot D; Thomas D; Emery C; Khoshnood B; Carrié A
    Atherosclerosis; 2017 Feb; 257():130-137. PubMed ID: 28131047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of European and US guidelines for familial hypercholesterolaemia.
    Reiner Ž
    Curr Opin Lipidol; 2015 Jun; 26(3):215-20. PubMed ID: 25943839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Role of Lipoprotein Apheresis.
    Thompson G; Parhofer KG
    Curr Atheroscler Rep; 2019 May; 21(7):26. PubMed ID: 31041550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.
    Santos RD; Gidding SS; Hegele RA; Cuchel MA; Barter PJ; Watts GF; Baum SJ; Catapano AL; Chapman MJ; Defesche JC; Folco E; Freiberger T; Genest J; Hovingh GK; Harada-Shiba M; Humphries SE; Jackson AS; Mata P; Moriarty PM; Raal FJ; Al-Rasadi K; Ray KK; Reiner Z; Sijbrands EJ; Yamashita S;
    Lancet Diabetes Endocrinol; 2016 Oct; 4(10):850-61. PubMed ID: 27246162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia.
    Kolovou G; Diakoumakou O; Kolovou V; Fountas E; Stratakis S; Zacharis E; Liberopoulos EN; Matsouka F; Tsoutsinos A; Mastorakou I; Katsikas T; Mavrogeni S; Hatzigeorgiou G
    Eur J Prev Cardiol; 2020 Jan; 27(2):157-165. PubMed ID: 31403880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors.
    Pećin I; Hartgers ML; Hovingh GK; Dent R; Reiner Ž
    Eur J Prev Cardiol; 2017 Sep; 24(13):1383-1401. PubMed ID: 28644091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances.
    Stefanutti C; Thompson GR
    Curr Atheroscler Rep; 2015 Jan; 17(1):465. PubMed ID: 25410046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and other lipid-lowering therapy and pregnancy outcomes in homozygous familial hypercholesterolaemia: A retrospective review of 39 pregnancies.
    Botha TC; Pilcher GJ; Wolmarans K; Blom DJ; Raal FJ
    Atherosclerosis; 2018 Oct; 277():502-507. PubMed ID: 30270091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017.
    Pottle A; Thompson G; Barbir M; Bayly G; Cegla J; Cramb R; Dawson T; Eatough R; Kale V; Neuwirth C; Nicholson K; Payne J; Scott J; Soran H; Walji S; Watkins S; Weedon H; Nath Datta DB
    Atherosclerosis; 2019 Nov; 290():44-51. PubMed ID: 31563836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management of children and young people with heterozygous familial hypercholesterolaemia - HEART UK statement of care.
    Ramaswami U; Humphries SE; Priestley-Barnham L; Green P; Wald DS; Capps N; Anderson M; Dale P; Morris AA
    Atherosclerosis; 2019 Nov; 290():1-8. PubMed ID: 31536851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial.
    Stefanutti C; Blom DJ; Averna MR; Meagher EA; Theron Hd; Marais AD; Hegele RA; Sirtori CR; Shah PK; Gaudet D; Vigna GB; Sachais BS; Di Giacomo S; du Plessis AM; Bloedon LT; Balser J; Rader DJ; Cuchel M;
    Atherosclerosis; 2015 Jun; 240(2):408-14. PubMed ID: 25897792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary treatment for familial hypercholesterolaemia.
    Poustie VJ; Rutherford P
    Cochrane Database Syst Rev; 2001; (2):CD001918. PubMed ID: 11406018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia-target attainment requires further increase of intensity.
    Klaus G; Taylan C; Büscher R; Schmitt CP; Pape L; Oh J; Driemeyer J; Galiano M; König J; Schürfeld C; Spitthöver R; Schaefer JR; Weber LT; Heibges A; Klingel R
    Pediatr Nephrol; 2018 Jul; 33(7):1199-1208. PubMed ID: 29502162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of familial hypercholesterolaemia in children and adolescents in the last three decades.
    Elis A; Zhou R; Stein EA
    Cardiol Young; 2014 Jun; 24(3):437-41. PubMed ID: 23659280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Homozygous familial hypercholesterolaemia: Spanish adaptation of the position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Consensus document of the Spanish Society of Arteriosclerosis (SEA) and Familial Hypercholesterolaemia Foundation (FHF)].
    Ascaso JF; Mata P; Arbona C; Civeira F; Valdivielso P; Masana L
    Clin Investig Arterioscler; 2015; 27(2):80-96. PubMed ID: 25757840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.